67. 多発性嚢胞腎 ［臨床試験数：186，薬物数：196（DrugBank：47），標的遺伝子数：35，標的パスウェイ数：146］
Searched query = "Polycystic kidney disease", "PKD", "PCKD", "Polycystic kidney", "ADPKD", "ARPKD"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||JPRN-UMIN000012865||2014/06/30||01/03/2014||Ursodeoxycholic acid for polycystic liver disease||Ursodeoxycholic acid for polycystic liver disease - UDCA for PLD||polycystic liver disease, polycystic kidney disease||UDCA 600mg/day|
|Nephrology Center, Toranomon Hospital||NULL||Recruiting||Not applicable||Not applicable||Male and Female||100||Not selected||Japan|
|December 2013||12/12/2013||Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease||An International, Multicenter, Randomized Controlled Clinical Trial Assessing the Efficacy of Ursodeoxycholic Acid as a Volume Reducing Treatment in Symptomatic Polycystic Liver Disease||Polycystic Liver Disease (PLD):;Polycystic Kidney, Autosomal Dominant;Polycystic Liver Disease||Drug: Ursodeoxycholic Acid||Radboud University||Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);Biodonostia Health Research Institute||Completed||18 Years||80 Years||Both||34||Phase 2||Netherlands;Spain|
|29/11/2013||08/08/2013||Trial to investigate the effect of ursodeoxycholic acid as a treatment of symptoms in polycystic liver disease: the CURSOR-trial||An international, multicenter, randomized controlled clinical trial assessing the efficacy of Ursodeoxycholic acid as a volume reducing treatment for symptomatic polycystic livers - The CURSOR trial||Patients suffering from symptomatic polycystic liver disease (PLD) with underlying diagnosis of isolated polycystic liver disease (PCLD) or autosomal dominant kidney disease (ADPKD);Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]||Trade Name: URSOCHOL 300||Radboud University Nijmegen Medical Center||NULL||Not Recruiting||Female: yes|